These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1677585)

  • 1. What the clinician can learn from MR glutamine/glutamate assays.
    Chamuleau RA; Bosman DK; Bovée WM; Luyten PR; den Hollander JA
    NMR Biomed; 1991 Apr; 4(2):103-8. PubMed ID: 1677585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation.
    Bosman DK; Deutz NE; De Graaf AA; vd Hulst RW; Van Eijk HM; Bovée WM; Maas MA; Jörning GG; Chamuleau RA
    Hepatology; 1990 Aug; 12(2):281-90. PubMed ID: 1975248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex.
    de Graaf AA; Deutz NE; Bosman DK; Chamuleau RA; de Haan JG; Bovee WM
    NMR Biomed; 1991 Feb; 4(1):31-7. PubMed ID: 1674207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 15N NMR study of in vivo cerebral glutamine synthesis in hyperammonemic rats.
    Kanamori K; Parivar F; Ross BD
    NMR Biomed; 1993; 6(1):21-6. PubMed ID: 8096147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy.
    Butterworth RF; Lavoie J; Giguère JF; Layrargues GP; Bergeron M
    Neurochem Pathol; 1987; 6(1-2):131-44. PubMed ID: 2888065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 15N-n.m.r. study of cerebral, hepatic and renal nitrogen metabolism in hyperammonaemic rats.
    Farrow NA; Kanamori K; Ross BD; Parivar F
    Biochem J; 1990 Sep; 270(2):473-81. PubMed ID: 1976007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine as a pathogenic factor in hepatic encephalopathy.
    Albrecht J; Dolińska M
    J Neurosci Res; 2001 Jul; 65(1):1-5. PubMed ID: 11433423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia.
    Zwingmann C
    J Neurosci Res; 2007 Nov; 85(15):3429-42. PubMed ID: 17722064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy.
    Taylor-Robinson SD; Buckley C; Changani KK; Hodgson HJ; Bell JD
    Liver; 1999 Oct; 19(5):389-98. PubMed ID: 10533796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.
    Häussinger D; Laubenberger J; vom Dahl S; Ernst T; Bayer S; Langer M; Gerok W; Hennig J
    Gastroenterology; 1994 Nov; 107(5):1475-80. PubMed ID: 7926510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute hyperammonemia on cerebral amino acid metabolism and pHi in vivo, measured by 1H and 31P nuclear magnetic resonance.
    Fitzpatrick SM; Hetherington HP; Behar KL; Shulman RG
    J Neurochem; 1989 Mar; 52(3):741-9. PubMed ID: 2563756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy.
    Braissant O; Rackayová V; Pierzchala K; Grosse J; McLin VA; Cudalbu C
    J Hepatol; 2019 Sep; 71(3):505-515. PubMed ID: 31173812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols.
    Kreis R; Farrow N; Ross BD
    NMR Biomed; 1991 Apr; 4(2):109-16. PubMed ID: 1650239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy.
    Zwingmann C; Butterworth R
    Neurochem Int; 2005 Jul; 47(1-2):19-30. PubMed ID: 15916833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.
    Laubenberger J; Häussinger D; Bayer S; Gufler H; Hennig J; Langer M
    Gastroenterology; 1997 May; 112(5):1610-6. PubMed ID: 9136840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease.
    Bosoi CR; Zwingmann C; Marin H; Parent-Robitaille C; Huynh J; Tremblay M; Rose CF
    J Hepatol; 2014 Mar; 60(3):554-60. PubMed ID: 24512824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy.
    Hawkins RA; Jessy J; Mans AM; De Joseph MR
    J Neurochem; 1993 Mar; 60(3):1000-6. PubMed ID: 8436955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during.
    Sibson NR; Mason GF; Shen J; Cline GW; Herskovits AZ; Wall JE; Behar KL; Rothman DL; Shulman RG
    J Neurochem; 2001 Feb; 76(4):975-89. PubMed ID: 11181817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy.
    Watanabe A; Takei N; Higashi T; Shiota T; Nakatsukasa H; Fujiwara M; Sakata T; Nagashima H
    Biochem Med; 1984 Oct; 32(2):225-31. PubMed ID: 6150706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites.
    Ross BD
    NMR Biomed; 1991 Apr; 4(2):59-63. PubMed ID: 1677586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.